Hexagon Nutrition IPO to Open on June 5 with Price Band of Rs 4245 per Share 3M India Announces Special Dividend of 506Share After Reporting Strong Q4 FY26 Results Bond Markets Signal Persistent Inflation Pressure Raising Stakes for US Policymakers EU Industry Commissioner Warns Against SingleCountry Supply Chain Reliance Amid China Tensions Shell SHEL Receives Rating Upgrade Following ARC Resources Transaction Oppenheimer Upgrades Quanta Services Stock Rating on Infrastructure Growth Prospects PLDT Inc PHI Q1 2026 Earnings EPS Misses Estimates as Stock Inches Higher HCA Q1 2026 Earnings EPS Slightly Misses Estimates Amid Steady Demand IPI Q1 2026 Earnings Strong EPS Beat Amid Challenging Market Conditions Community Healthcare Trust Incorporated CHCT Q1 2026 Earnings Massive Earnings Surprise as Profitability Rebounds Sharply ORKA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline VSECU Q1 2026 Earnings Strong EPS Surprise Drives Positive Stock Reaction Lipocine Inc LPCN Shows Modest Uptick Trading Near Key Resistance Level Brandywine Realty Trust BDN Holds Near 300 as Bulls Test Resistance Zone AEFC Edges Higher Amid Steady Trading Key Levels in Focus MeiraGTx Holdings MGTX Holds Near Key Resistance After Modest Gain Star Equity Holdings STRR Edges Higher Key Levels and Momentum in Focus Amazon Allegedly Generated Millions Through NowIllegal Pricing Policy WDS Q4 2025 Earnings Earnings per share beat estimates by over 33 amid strong operational performance Tesla TSLA Advances 195 as Momentum Builds Toward Resistance at 44731 nVent Electric NVT Q1 2026 Earnings Strong EPS Beat Drives Slight Stock Uptick PKX Q4 2025 Earnings Massive EPS Miss Exceeds Negative Surprise Amidst Challenging Conditions CMDB Q1 2026 Earnings Positive EPS Amid Quiet Market Reaction Castle Biosciences Q1 2026 Earnings NarrowerThanExpected Loss Stock Slips 111 Inc Q3 2024 Earnings Narrowed Loss per ADS Supports Positive Stock Movement RILYP Q1 2024 Earnings Preferred Shares Report Negative EPS Amid No Revenue or Estimate PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response